Avid Bioservices

Rank#5880

Market Cap798.90M

CountryUnited States

Summary

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

History

Avid Bioservices was incorporated in the state of Delaware on October 19, 2001. The Company was formed to develop and operate a specialized biopharmaceutical contract manufacturing business. Prior to our reverse merger with Avid Bioservices and its predecessor companies, our company was known as Titarium Corporation, a Delaware corporation that was organized on April 15, 1999.

Mission

Avid’s mission is to help biopharmaceutical companies bring complex and innovative therapies to market by providing specialized process development and cGMP manufacturing services for clinical and commercial supply.

Vision

To be the leader in specialized process development and cGMP manufacturing of biopharmaceuticals to the global biopharmaceutical companies.

References

https://in.investing.com/equities/peregrine-pharmaceuticals-earnings

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/avid-biosciences

https://finance.yahoo.com/quote/CDMO/

https://www.avidbio.com

https://sec.report/CIK/0000704562

Leadership team

Mr. Nicholas Stewart Green B.Sc., MBA (Pres, CEO & Director)

Mr. Daniel R. Hart (Chief Financial Officer)